Skip to content

Skeletonised Versus Pedicled Internal Thoracic Artery

Skeletonised Versus Pedicled Internal Thoracic Artery - A Randomised Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05562908
Acronym
TST
Enrollment
165
Registered
2022-10-03
Start date
2019-04-01
Completion date
2021-11-30
Last updated
2022-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Diseases

Keywords

coronary artery diseases, left internal mammary artery, LIMA harvesting, flow, quality of life

Brief summary

It is to date unknown whether Thunderbeat has a place in harvesting the left internal mammary artery (LIMA) and whether skeletonisation is superior to pedicle harvested LIMA. Though, some studies have shown improved flow-rates in the skeletonised graft while others shows compromised blood flow to the thoracic wall after pedicle harvested LIMA. The purpose of this study is to improve the quality of life for patients undergoing coronary artery bypass graft (CABG) operations. The aim of this study is to compare three groups of LIMA harvesting techniques: Pedicled, surgical skeletonised and skeletonised with Thunderbeat to determine the best way to harvest LIMA during CABG operations. The study design is an experimental randomized controlled trial in a single centre. Study population: Adult patients enlisted for elective stand-alone CABG surgery at the Department of Cardiothoracic surgery, Odense University Hospital. Study Unit: Test-days within subject and subject The study will address two main hypotheses in CABG patients: 1. That both the surgical skeletonised and Thunderbeat skeletonised harvesting techniques of LIMA are superior to pedicled harvesting in regards to flowrates and pulsatility index (PI). 2. Skeletonized harvesting of LIMA graft compared to pedicled harvesting improves patient quality of life three days, 30 days, and six months postoperatively.

Interventions

PROCEDUREPedicled

Surgical procedure: A prior marking was made on both sides of the LIMA and its veins with bi-polar technique. Hereafter the LIMA and its veins were dissected free with scissor and forceps. Clips were added to all side branches. When the full length of LIMA was obtained, the LIMA and its veins were divided distally by adding clips on the peripheral part of the vessels and proximately dividing by scissor. A vessel-clamp was placed distally and the pedicled LIMA placed in the jugular cavity with a cloth containing papaverine.

PROCEDURESurgical skeletonised

Surgical procedure: The fascia of the LIMA was opened with a scissor. Hereafter the LIMA was dissected free with scissor and forceps, clips on all LIMA side-branches and divided by scissor. When the full length of LIMA was obtained, the LIMA was divided distally by adding clips on the peripheral part of the vessel and proximately dividing by scissor. A vessel-clamp was placed distally, and the skeletonised LIMA placed in the jugular cavity with a cloth containing papaverine.

PROCEDUREThunderbeat skeletonised

Surgical procedure: With Thunderbeat the fascia of LIMA was opened. The LIMA was dissected free with Thunderbeat including all side-branches. When the full length of the LIMA was obtained, the LIMA was divided distally by adding clips on the peripheral part of the vessel and proximately dividing by scissor. A vessel-clamp was placed distally, and the skeletonised LIMA placed in the jugular cavity with a cloth containing papaverine.

Sponsors

Odense Patient Data Explorative Network
CollaboratorOTHER
GCP-unit at Odense University Hospital
CollaboratorUNKNOWN
Lars Peter Riber
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

After randomisation, the attending consultant informed the patient of the harvesting method. Data collector and outcome adjudicator were blinded.

Intervention model description

Randomised trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stand-alone CABG (surgical removal of the left atrial appendage (LAAX) is accepted, since it doesn't affect the graft area) * On-pump with cardioplegia (otherwise one cannot be sure of the pressure and perfusion during surgery of the graft) * Patients aged \>18 * Elective surgery (there is a known higher risk of postoperative complications with urgent surgery)

Exclusion criteria

* CABG combined with other heart surgery, except from LAAX * Previous heart surgery * LVEF \< 40% (there is a known higher risk of postoperative complications with low LVEF) * Known cancers (there is a known higher risk of postoperative complication) * Thoracic radiation therapy (there is a known higher risk of postoperative complication) * Severe chronic obstructive pulmonary disease (COPD) (there is a known higher risk of postoperative complication) * Patients not able to understand written consent * Urgent and emergent surgery (there is a known higher risk of postoperative complication)

Design outcomes

Primary

MeasureTime frameDescription
Differences in flow in LIMA and pulssatility index between the three groups.Perioperative - After weaning off the extracorporeal circulation just before closing the thoraxmL/ min With transit time flowmetry (Sono TT flowlab), the graft flow and peripheral index (PI) are measured after weaning off the extracorporeal circulation with a systolic pressure aimed at 100 mmHg. The measurements are done with probe size 3 or 4.

Secondary

MeasureTime frameDescription
Re-operation due to bleedingUp to 48 hours calculated from the end of primaery surgeryNumber of patients in each group
Re-operation due to ischemiaUp to 48 hours calculated from the end of primaery surgeryNumber of patients in each group
PleurocentesisUp to 10 days calculated from the end of primaery surgeryNumber of patients in each group
Myocardial injury - creatine kinase-MB (CK-MB)Routine bloodsample measured four hours after aortic cross clamp removal.Unit: (µg/L)
Myocardial injury - cardiac troponin (cTn)Routine bloodsample measured four hours after aortic cross clamp removal.Unit: (ng/L)
Differences in pre and post operative regional oxygen saturation on the thorax.Measured 7 days prior to surgery and again 3 days after surgeryUnit: oxygen saturation (rSO2)
Length of stay on ICUDay of surgery to the day of discharge from ICU. Up to 52 weeksUnit: Days
Length of stay in hospitalDay of surgery to the day of discharge from hospital. Up to 52 weeksUnit: Days
EQ-5D-5L questionnaire: differences in self reported assessment of patient quality of life between the 3 groupsQuestionnaires uptained the week before the date of surgery and again 3, 30, and 180 days after surgery.Developed by the EURO-QoF group in 1990 to describe five dimensions of quality of life: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels: no problems, slight problems, moderate problems, severe problems and extreme problems and a visual analogue scale recording the patient's self-rated health.
Postoperative bleedingPostoperative bleeding is measured from the end of the operation to removal of the mediastinal drains in the intensive care unitUnit: mL
Rate of readmission to hospital due to Major adverse cardiac and cerebrovascular events (MACCE) - earlyEarly (≤30 days)Number of deaths in each group
Rate of readmission to hospital due to Major adverse cardiac and cerebrovascular events (MACCE) - IntermediateIntermediate (≤180 days)Number of deaths in each group
Rate of readmission to hospital due to Major adverse cardiac and cerebrovascular events (MACCE) - LongLong (≤2 years)Number of deaths in each group
Rate of mortality due to cardiac event - EarlyEarly (≤30 days)Number of deaths in each group
Rate of mortality due to cardiac event - IntermediateIntermediate (≤180 days)Number of deaths in each group
Rate of mortality due to cardiac event - IongLong (≤2 years)Number of deaths in each group
Rate of all-cause mortality - EarlyEarly (≤30 days)Number of deaths in each group
Rate of all-cause mortality - IntermediateIntermediate (≤180 days)Number of deaths in each group
Rate of all-cause mortality - longLong (≤ 2 years)Number of deaths in each group
Telephone interview - Questions regarding pain, numbness and wound healing around the thoracic incision.180 ± 7 days calculated from the date of surgery.All questions are closed questions and qualitative variables (yes/no)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026